• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高效抗逆转录病毒治疗时代卡波西肉瘤患者的特征

Profile of patients with Kaposi's sarcoma in the era of highly active antiretroviral therapy.

作者信息

Gallafent James H, Buskin Susan E, De Turk Peter B, Aboulafia David M

机构信息

University of Washington, School of Medicine, Department of Epidemiology, Seattle, WA, USA.

出版信息

J Clin Oncol. 2005 Feb 20;23(6):1253-60. doi: 10.1200/JCO.2005.04.156.

DOI:10.1200/JCO.2005.04.156
PMID:15718323
Abstract

PURPOSE

Since the advent of highly active antiretroviral therapy (HAART), the incidence of Kaposi's sarcoma (KS) among AIDS patients has declined both nationwide and in King County, Washington. We sought to compare clinical parameters of patients diagnosed with KS in the pre-HAART (1990 to 1996) and HAART (1997 to 2002) eras.

METHODS

We used patient data abstracted from the Adult/Adolescent Spectrum of HIV-Related Diseases study of Public Health-Seattle and King County.

RESULTS

Patients diagnosed with KS in the HAART era (n = 40) were significantly more likely (P < .05) than pre-HAART-era KS patients (n = 366) to be diagnosed with alcohol problems (43% v 18%), noninjection drug use (45% v 18%), injection drug use (25% v 10%), psychosis (25% v 13%), and hypertension (13% v 2%). Although median CD4(+) count and HIV-1 viral load at the time of KS diagnosis were not significantly different between the two groups, significantly fewer (P < .01) HAART-era KS patients developed opportunistic illnesses (OIs) during their follow-up. The risk of dying among KS patients diagnosed in the HAART era is significantly lower (P < .01) than for KS patients diagnosed in the pre-HAART era (hazard ratio, 0.24).

CONCLUSION

Although HAART-era KS patients in King County were as likely to have a depleted CD4(+) cell count and high HIV-1 viral loads at the time of KS diagnosis as pre-HAART KS patients, they survived longer and fewer of them were diagnosed with other OIs. They also had an increased prevalence of substance abuse and mental illness, contributing to a dynamic and changing KS clinical profile.

摘要

目的

自从高效抗逆转录病毒疗法(HAART)问世以来,美国全国以及华盛顿州金县的艾滋病患者中卡波西肉瘤(KS)的发病率均有所下降。我们试图比较在HAART时代之前(1990年至1996年)和HAART时代(1997年至2002年)被诊断为KS的患者的临床参数。

方法

我们使用了从西雅图和金县公共卫生部门的成人/青少年HIV相关疾病谱研究中提取的患者数据。

结果

在HAART时代被诊断为KS的患者(n = 40)比HAART时代之前被诊断为KS的患者(n = 366)更有可能(P <.05)被诊断出有酒精问题(43%对18%)、非注射吸毒(45%对18%)、注射吸毒(25%对10%)、精神病(25%对13%)和高血压(13%对2%)。尽管两组在KS诊断时的CD4(+)细胞计数中位数和HIV-1病毒载量没有显著差异,但在随访期间,HAART时代的KS患者发生机会性感染(OIs)的人数明显较少(P <.01)。在HAART时代被诊断为KS的患者的死亡风险明显低于HAART时代之前被诊断为KS的患者(P <.01)(风险比,0.24)。

结论

尽管金县HAART时代的KS患者在KS诊断时CD4(+)细胞计数减少和HIV-1病毒载量高的可能性与HAART时代之前的KS患者相同,但他们存活的时间更长,被诊断出患有其他OIs的人数也更少。他们的药物滥用和精神疾病患病率也有所增加,这导致了KS临床特征的动态变化。

相似文献

1
Profile of patients with Kaposi's sarcoma in the era of highly active antiretroviral therapy.高效抗逆转录病毒治疗时代卡波西肉瘤患者的特征
J Clin Oncol. 2005 Feb 20;23(6):1253-60. doi: 10.1200/JCO.2005.04.156.
2
Kaposi's sarcoma in patients with human immunodeficiency virus infection in Taiwan.台湾地区人类免疫缺陷病毒感染患者的卡波西肉瘤。
J Microbiol Immunol Infect. 2009 Jun;42(3):227-33.
3
AIDS-related Kaposi's Sarcoma: evaluation of potential new prognostic factors and assessment of the AIDS Clinical Trial Group Staging System in the Haart Era--the Italian Cooperative Group on AIDS and Tumors and the Italian Cohort of Patients Naive From Antiretrovirals.艾滋病相关卡波西肉瘤:在高效抗逆转录病毒治疗时代评估潜在的新预后因素及艾滋病临床试验组分期系统——意大利艾滋病与肿瘤合作组及意大利未接受过抗逆转录病毒治疗患者队列
J Clin Oncol. 2003 Aug 1;21(15):2876-82. doi: 10.1200/JCO.2003.10.162.
4
The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinic.伦敦一家诊所引入高效抗逆转录病毒疗法(HAART)后,艾滋病界定疾病模式的变化。
J Infect. 2001 Feb;42(2):134-9. doi: 10.1053/jinf.2001.0810.
5
The changing pattern of Kaposi sarcoma in patients with HIV, 1994-2003: the EuroSIDA Study.1994 - 2003年HIV患者中卡波西肉瘤的变化模式:欧洲SIDA研究
Cancer. 2004 Jun 15;100(12):2644-54. doi: 10.1002/cncr.20309.
6
Long-term clinical outcome of AIDS-related Kaposi's sarcoma during highly active antiretroviral therapy.高效抗逆转录病毒治疗期间艾滋病相关卡波西肉瘤的长期临床结局
Int J Oncol. 2005 Sep;27(3):779-85.
7
Delayed progression to death and to AIDS in a Hong Kong cohort of patients with advanced HIV type 1 disease during the era of highly active antiretroviral therapy.在高效抗逆转录病毒治疗时代,香港一组晚期1型艾滋病毒病患者的死亡和艾滋病进展延迟情况。
Clin Infect Dis. 2004 Sep 15;39(6):853-60. doi: 10.1086/423183. Epub 2004 Aug 27.
8
The effect of HAART in 254 consecutive patients with AIDS-related Kaposi's sarcoma.高效抗逆转录病毒治疗对254例连续性艾滋病相关卡波西肉瘤患者的疗效。
AIDS. 2009 Aug 24;23(13):1701-6. doi: 10.1097/QAD.0b013e32832d080d.
9
Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.卡波西肉瘤相关疱疹病毒特异性免疫重建以及高效抗逆转录病毒治疗/化疗联合方案对感染C型HIV且患有卡波西肉瘤个体的抗病毒作用
AIDS. 2007 Jun 19;21(10):1245-52. doi: 10.1097/QAD.0b013e328182df03.
10
AIDS-related Burkitt's lymphoma versus diffuse large-cell lymphoma in the pre-highly active antiretroviral therapy (HAART) and HAART eras: significant differences in survival with standard chemotherapy.高效抗逆转录病毒治疗(HAART)前及HAART时代艾滋病相关伯基特淋巴瘤与弥漫性大细胞淋巴瘤:标准化疗生存率的显著差异
J Clin Oncol. 2005 Jul 1;23(19):4430-8. doi: 10.1200/JCO.2005.11.973. Epub 2005 May 9.

引用本文的文献

1
Kaposi sarcoma in an HIV-infected patient with high CD4 count: a case report and literature review.一名CD4计数高的HIV感染患者的卡波西肉瘤:病例报告及文献综述
Front Med (Lausanne). 2025 Apr 25;12:1496863. doi: 10.3389/fmed.2025.1496863. eCollection 2025.
2
Association between KSHV-Specific Humoral and T Cell Responses with Recurrence of HIV-Associated Kaposi Sarcoma.卡波西肉瘤相关疱疹病毒特异性体液免疫和T细胞反应与HIV相关卡波西肉瘤复发之间的关联
Trop Med Infect Dis. 2024 Jun 18;9(6):134. doi: 10.3390/tropicalmed9060134.
3
Kaposi's Sarcoma: Evaluation of Clinical Features, Treatment Outcomes, and Prognosis in a Single-Center Retrospective Case Series.
卡波西肉瘤:单中心回顾性病例系列中临床特征、治疗结果及预后的评估
Cancers (Basel). 2024 Feb 6;16(4):691. doi: 10.3390/cancers16040691.
4
Soluble biomarkers of HIV-1-related systemic immune activation are associated with high plasma levels of growth factors implicated in the pathogenesis of Kaposi sarcoma in adults.可溶性 HIV-1 相关系统免疫激活生物标志物与成人卡波西肉瘤发病机制中涉及的生长因子的高血浆水平相关。
Front Immunol. 2023 Sep 18;14:1216480. doi: 10.3389/fimmu.2023.1216480. eCollection 2023.
5
Kaposi sarcoma presenting as small bowel obstruction.以小肠梗阻为表现的卡波西肉瘤。
J Surg Case Rep. 2023 Jul 3;2023(7):rjad385. doi: 10.1093/jscr/rjad385. eCollection 2023 Jul.
6
Rapidly Disseminated Kaposi's Sarcoma Despite Initiation of Antiretroviral Therapy.尽管开始了抗逆转录病毒治疗,但卡波西肉瘤仍迅速播散。
Cureus. 2023 May 29;15(5):e39627. doi: 10.7759/cureus.39627. eCollection 2023 May.
7
Clinicopathological Features and Mortality in Patients With Kaposi Sarcoma and HIV: A Retrospective Analysis of a Thirty-Year Study From a Peruvian Oncologic Center.卡波西肉瘤和 HIV 患者的临床病理特征和死亡率:秘鲁肿瘤中心三十年回顾性研究分析。
JCO Glob Oncol. 2022 Jun;8:e2100379. doi: 10.1200/GO.21.00379.
8
Therapeutic management of a symptomatic Kaposi's sarcoma patient with renal failure undergoing haemodialysis: A case report.一名接受血液透析的有症状的卡波西肉瘤合并肾衰竭患者的治疗管理:病例报告
Dermatol Reports. 2021 Oct 29;14(1):9113. doi: 10.4081/dr.2022.9113. eCollection 2022 Mar 11.
9
Antiretroviral therapy and Kaposi's sarcoma trends and outcomes among adults with HIV in Latin America.拉丁美洲成人艾滋病毒感染者的抗逆转录病毒治疗、卡波西肉瘤趋势及转归
J Int AIDS Soc. 2021 Jan;24(1):e25658. doi: 10.1002/jia2.25658.
10
Intractable pleural effusion in Kaposi sarcoma following antiretroviral therapy in a Caucasian female infected with HIV.一名感染HIV的白人女性在接受抗逆转录病毒治疗后出现卡波西肉瘤相关的顽固性胸腔积液。
BMJ Case Rep. 2020 Feb 28;13(2):e233335. doi: 10.1136/bcr-2019-233335.